Category: Pharmaceutical industry management Pharmaceutical researchers Process Analytical Technologies The Pharma Industry Pfizer Pharma Workforce and Staffing Pharmaceutical Mergers and Acquisitions Pharmaceutical Industry CEOs Quality Accountability Pharmaceutical Industry Reputation Pfizer Sandwich Pfizer Wyeth Pharma Ceo's Wy-pfi Merger
Submitted by pharmamanufacturing on Thu, 02/03/2011 - 09:38
Submitted by pharmamanufacturing on Wed, 12/08/2010 - 09:12
Fewer and fewer of the men (and occasionally women) that are chosen to head up drug companies come from a scientific background. Most are businesspeople by trade, or perhaps accountants and economists. Merck's incoming CEO Ken Frazier, who takes over for Richard Clark upon his forced retirement at 65, is...
Category: Pharmaceutical industry management cGxP's FDA and Regulatory Issues The Pharma Industry Pharmaceutical Industry CEOs Quality Accountability
Submitted by pharmamanufacturing on Thu, 11/11/2010 - 11:49
Uberblogger Pharmagossip and the expert satirist Pharmagiles recently posted riffs inspired by the GSK whistleblower case, with Pharmagiles setting the lyrics to Harry Belafonte's famous Banana Boat Song. Click here for a view.
Category: management FDA cGxP's FDA and Regulatory Issues The Pharma Industry GSK Pharmaceutical Industry CEOs Facility Toyota Operational Excellence Whistleblower Jp Garnier Corporate Ethics Alan G. Minsk Diana Rusk Cohen Arnall Golden Gregory
Submitted by pharmamanufacturing on Thu, 11/04/2010 - 15:22
A growing number of pharma CEOs are now dealing with the consequences of failing to care about workplace realities and what Toyota called the gemba, or place where truth will be found.If the idea of reading a book on ethics or philosophy is too off-putting....after all, it has been a...
Category: management FDA cGxP's FDA and Regulatory Issues The Pharma Industry Pharma Workforce and Staffing Pharmaceutical Industry CEOs Facility Operational Excellence Quality Whistleblower Cheryl Eckard
Submitted by pharmamanufacturing on Wed, 11/03/2010 - 20:37
Pharma whistleblowers don't always fare too well...especially those who deal with the invisible world of manufacturing. Remember Mark Livingston and the Wyeth Sarbanes-Oxley case? However, Cheryl Eckard, who pointed out manufacturing deficiencies at GSK's Cidra, Puerto Rico, plant has received a $96-million payment. For more from The Guardian, read on.
Category: FDA cGxP's FDA and Regulatory Issues Lean Six Sigma and Quality Improvement The Pharma Industry Pharma Workforce and Staffing Pharmaceutical Industry CEOs J&J Toyota 483's Tunnell Consulting Operational Excellence Quality Operator Error CDER OEE Ajaz Hussain Park Doctrine Accountability Misdemeanor Charges For Pharma Ceos Ray Scherzer Ken Leiper
Submitted by pharmamanufacturing on Tue, 08/31/2010 - 11:31
Just read Mina Kimes' enlightening account of the J&J McNeil quality disaster in Fortune. Forget about the fact that the adulterated products did not and most likely would not have harmed consumers, the problems cited are very serious and go straight to the heart of GMP's.
Category: Lean Six Sigma and Quality Improvement New Drug Pipeline and R&D Pharmaceutical Industry CEOs Genzyme management Research And Development Lean Manufacturing Operational Excellence Quality
Submitted by pharmamanufacturing on Mon, 08/03/2009 - 10:09
Every so often, one gets a major reminder of the strategic importance of manufacturing and the largely invisible "CGMP set" to the drug industry and, yes, its bottom line. Former FDA chief Mark McClellan gave pharma a good one years ago with his famous "potato chips and soap flakes" comment,...
Category: management The Pharma Industry India China and Asian Pharma Pharma Workforce and Staffing Pharmaceutical Industry CEOs Pharmaceutical Industry Videos Obama John Lechleiter
Submitted by pharmamanufacturing on Thu, 05/07/2009 - 15:37
Did anyone miss President Obama's recent announcement that he plans to put an end to corporate tax loopholes (a mainstay for every major pharma and biotech company in the world....)More from Bloomberg and the President himself.
Category: management Pharmaceutical Industry CEOs Pharmaceutical Industry Videos Supply Chain Management Susan Boyle David Brennan
Submitted by pharmamanufacturing on Fri, 04/17/2009 - 16:08
Busy and eventful week. Michele's on her way to Ireland to visit biotech and pharma labs, and Paul had nice interviews with AstraZeneca's CEO David Brennan and former House majority leader Dick Gephardt.
Category: FDA New Drug Pipeline and R&D AstraZeneca India China and Asian Pharma Pharmaceutical Patents and Intellectual Property Biotechnology and biopharmaceuticals Pharmaceutical Industry CEOs medical research drug development orphan drugs Obama R&d Gephardt
Submitted by pharmamanufacturing on Thu, 04/16/2009 - 10:08
I spent yesterday afternoon at the Forum for Medical Innovation in downtown Chicago, hosted by the Council for American Medical Innovation and moderated by former U.S. House of Representatives majority leader Dick Gephardt. The event also featured AstraZeneca CEO David Brennan as a guest speaker. [img_assist|nid=1172|title=David Brennan|desc=|link=none|align=right|width=128|height=86]